BLUELINX HOLDINGS INC (BXC) Fundamental Analysis & Valuation

NYSE:BXC • US09624H2085

56.71 USD
-1.81 (-3.09%)
At close: Mar 10, 2026
56.71 USD
0 (0%)
After Hours: 3/10/2026, 8:09:39 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This BXC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to BXC. BXC was compared to 46 industry peers in the Trading Companies & Distributors industry. BXC scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, BXC is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. BXC Profitability Analysis

1.1 Basic Checks

  • In the past year BXC was profitable.
  • In the past year BXC had a positive cash flow from operations.
  • Each year in the past 5 years BXC has been profitable.
  • In the past 5 years BXC always reported a positive cash flow from operatings.
BXC Yearly Net Income VS EBIT VS OCF VS FCFBXC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M

1.2 Ratios

  • The Return On Assets of BXC (0.01%) is worse than 60.87% of its industry peers.
  • BXC has a worse Return On Equity (0.04%) than 63.04% of its industry peers.
  • BXC has a Return On Invested Capital of 1.69%. This is in the lower half of the industry: BXC underperforms 67.39% of its industry peers.
  • BXC had an Average Return On Invested Capital over the past 3 years of 4.86%. This is below the industry average of 9.05%.
Industry RankSector Rank
ROA 0.01%
ROE 0.04%
ROIC 1.69%
ROA(3y)2.18%
ROA(5y)9.78%
ROE(3y)5.3%
ROE(5y)29.53%
ROIC(3y)4.86%
ROIC(5y)14.09%
BXC Yearly ROA, ROE, ROICBXC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 200 300

1.3 Margins

  • The Profit Margin of BXC (0.01%) is worse than 63.04% of its industry peers.
  • BXC's Profit Margin has declined in the last couple of years.
  • BXC's Operating Margin of 1.02% is on the low side compared to the rest of the industry. BXC is outperformed by 69.57% of its industry peers.
  • In the last couple of years the Operating Margin of BXC has declined.
  • BXC has a Gross Margin of 15.29%. This is amonst the worse of the industry: BXC underperforms 84.78% of its industry peers.
  • BXC's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 1.02%
PM (TTM) 0.01%
GM 15.29%
OM growth 3Y-51.87%
OM growth 5Y-23.7%
PM growth 3Y-89.63%
PM growth 5Y-69.05%
GM growth 3Y-6.52%
GM growth 5Y-0.17%
BXC Yearly Profit, Operating, Gross MarginsBXC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. BXC Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BXC is destroying value.
  • Compared to 1 year ago, BXC has less shares outstanding
  • The number of shares outstanding for BXC has been reduced compared to 5 years ago.
  • Compared to 1 year ago, BXC has a worse debt to assets ratio.
BXC Yearly Shares OutstandingBXC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M
BXC Yearly Total Debt VS Total AssetsBXC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • An Altman-Z score of 3.34 indicates that BXC is not in any danger for bankruptcy at the moment.
  • BXC has a Altman-Z score (3.34) which is in line with its industry peers.
  • BXC has a debt to FCF ratio of 18.81. This is a negative value and a sign of low solvency as BXC would need 18.81 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 18.81, BXC is in line with its industry, outperforming 50.00% of the companies in the same industry.
  • BXC has a Debt/Equity ratio of 0.96. This is a neutral value indicating BXC is somewhat dependend on debt financing.
  • BXC has a Debt to Equity ratio of 0.96. This is in the lower half of the industry: BXC underperforms 60.87% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.96
Debt/FCF 18.81
Altman-Z 3.34
ROIC/WACC0.17
WACC10.06%
BXC Yearly LT Debt VS Equity VS FCFBXC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

  • BXC has a Current Ratio of 4.66. This indicates that BXC is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 4.66, BXC belongs to the best of the industry, outperforming 95.65% of the companies in the same industry.
  • BXC has a Quick Ratio of 3.12. This indicates that BXC is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 3.12, BXC belongs to the top of the industry, outperforming 95.65% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.66
Quick Ratio 3.12
BXC Yearly Current Assets VS Current LiabilitesBXC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. BXC Growth Analysis

3.1 Past

  • The earnings per share for BXC have decreased strongly by -85.11% in the last year.
  • BXC shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -35.32% yearly.
  • Looking at the last year, BXC shows a small growth in Revenue. The Revenue has grown by 0.05% in the last year.
  • Measured over the past years, BXC shows a decrease in Revenue. The Revenue has been decreasing by -0.94% on average per year.
EPS 1Y (TTM)-85.11%
EPS 3Y-68.55%
EPS 5Y-35.32%
EPS Q2Q%-177.05%
Revenue 1Y (TTM)0.05%
Revenue growth 3Y-12.77%
Revenue growth 5Y-0.94%
Sales Q2Q%0.73%

3.2 Future

  • The Earnings Per Share is expected to grow by 85.45% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 5.38% on average over the next years.
EPS Next Y-41.26%
EPS Next 2Y85.45%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.9%
Revenue Next 2Y5.38%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BXC Yearly Revenue VS EstimatesBXC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B
BXC Yearly EPS VS EstimatesBXC Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 10 20 30

More info and screens

Find the best growth stocksShow best growing peers

3

4. BXC Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 59.69, BXC can be considered very expensive at the moment.
  • Based on the Price/Earnings ratio, BXC is valued a bit more expensive than the industry average as 65.22% of the companies are valued more cheaply.
  • The average S&P500 Price/Earnings ratio is at 26.25. BXC is valued rather expensively when compared to this.
  • The Price/Forward Earnings ratio is 101.63, which means the current valuation is very expensive for BXC.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of BXC indicates a slightly more expensive valuation: BXC is more expensive than 67.39% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 24.39. BXC is valued rather expensively when compared to this.
Industry RankSector Rank
PE 59.69
Fwd PE 101.63
BXC Price Earnings VS Forward Price EarningsBXC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • 69.57% of the companies in the same industry are more expensive than BXC, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, BXC is valued cheaper than 84.78% of the companies in the same industry.
Industry RankSector Rank
P/FCF 13.59
EV/EBITDA 9.9
BXC Per share dataBXC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 100 200 300

4.3 Compensation for Growth

  • A more expensive valuation may be justified as BXC's earnings are expected to grow with 85.45% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y85.45%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BXC Dividend Analysis

5.1 Amount

  • BXC does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BXC Fundamentals: All Metrics, Ratios and Statistics

BLUELINX HOLDINGS INC

NYSE:BXC (3/10/2026, 8:09:39 PM)

After market: 56.71 0 (0%)

56.71

-1.81 (-3.09%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)02-24
Earnings (Next)04-27
Inst Owners100.59%
Inst Owner Change1.59%
Ins Owners2.21%
Ins Owner Change0.01%
Market Cap446.31M
Revenue(TTM)2.95B
Net Income(TTM)219.00K
Analysts77.5
Price Target78.03 (37.59%)
Short Float %6.11%
Short Ratio4.82
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-16.66%
Min EPS beat(2)-23.18%
Max EPS beat(2)-10.14%
EPS beat(4)1
Avg EPS beat(4)-14.28%
Min EPS beat(4)-24.67%
Max EPS beat(4)0.88%
EPS beat(8)4
Avg EPS beat(8)9.11%
EPS beat(12)7
Avg EPS beat(12)11.85%
EPS beat(16)10
Avg EPS beat(16)12.41%
Revenue beat(2)1
Avg Revenue beat(2)-0.69%
Min Revenue beat(2)-2.07%
Max Revenue beat(2)0.69%
Revenue beat(4)1
Avg Revenue beat(4)-1.06%
Min Revenue beat(4)-2.07%
Max Revenue beat(4)0.69%
Revenue beat(8)3
Avg Revenue beat(8)-0.71%
Revenue beat(12)3
Avg Revenue beat(12)-2.91%
Revenue beat(16)5
Avg Revenue beat(16)-1.52%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-61.78%
EPS NQ rev (3m)-69.7%
EPS NY rev (1m)-70.61%
EPS NY rev (3m)-71.45%
Revenue NQ rev (1m)0.95%
Revenue NQ rev (3m)0.65%
Revenue NY rev (1m)0.82%
Revenue NY rev (3m)0.68%
Valuation
Industry RankSector Rank
PE 59.69
Fwd PE 101.63
P/S 0.15
P/FCF 13.59
P/OCF 7.47
P/B 0.72
P/tB 0.96
EV/EBITDA 9.9
EPS(TTM)0.95
EY1.68%
EPS(NY)0.56
Fwd EY0.98%
FCF(TTM)4.17
FCFY7.36%
OCF(TTM)7.6
OCFY13.4%
SpS375.35
BVpS78.44
TBVpS58.88
PEG (NY)N/A
PEG (5Y)N/A
Graham Number40.95
Profitability
Industry RankSector Rank
ROA 0.01%
ROE 0.04%
ROCE 2.25%
ROIC 1.69%
ROICexc 2.37%
ROICexgc 2.83%
OM 1.02%
PM (TTM) 0.01%
GM 15.29%
FCFM 1.11%
ROA(3y)2.18%
ROA(5y)9.78%
ROE(3y)5.3%
ROE(5y)29.53%
ROIC(3y)4.86%
ROIC(5y)14.09%
ROICexc(3y)7.81%
ROICexc(5y)17.95%
ROICexgc(3y)8.79%
ROICexgc(5y)19.65%
ROCE(3y)6.47%
ROCE(5y)18.75%
ROICexgc growth 3Y-56.47%
ROICexgc growth 5Y-25.31%
ROICexc growth 3Y-57.61%
ROICexc growth 5Y-26.66%
OM growth 3Y-51.87%
OM growth 5Y-23.7%
PM growth 3Y-89.63%
PM growth 5Y-69.05%
GM growth 3Y-6.52%
GM growth 5Y-0.17%
F-Score5
Asset Turnover1.91
Health
Industry RankSector Rank
Debt/Equity 0.96
Debt/FCF 18.81
Debt/EBITDA 8.51
Cap/Depr 67.49%
Cap/Sales 0.91%
Interest Coverage 0.64
Cash Conversion 85.42%
Profit Quality 15000.5%
Current Ratio 4.66
Quick Ratio 3.12
Altman-Z 3.34
F-Score5
WACC10.06%
ROIC/WACC0.17
Cap/Depr(3y)85.86%
Cap/Depr(5y)87.75%
Cap/Sales(3y)1.05%
Cap/Sales(5y)0.86%
Profit Quality(3y)5219.88%
Profit Quality(5y)3165.36%
High Growth Momentum
Growth
EPS 1Y (TTM)-85.11%
EPS 3Y-68.55%
EPS 5Y-35.32%
EPS Q2Q%-177.05%
EPS Next Y-41.26%
EPS Next 2Y85.45%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.05%
Revenue growth 3Y-12.77%
Revenue growth 5Y-0.94%
Sales Q2Q%0.73%
Revenue Next Year3.9%
Revenue Next 2Y5.38%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-65.73%
EBIT growth 3Y-58.02%
EBIT growth 5Y-24.42%
EBIT Next Year80.11%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-27.11%
FCF growth 3Y-55.16%
FCF growth 5Y-8.53%
OCF growth 1Y-29.81%
OCF growth 3Y-46.94%
OCF growth 5Y1.68%

BLUELINX HOLDINGS INC / BXC FAQ

What is the fundamental rating for BXC stock?

ChartMill assigns a fundamental rating of 4 / 10 to BXC.


What is the valuation status of BLUELINX HOLDINGS INC (BXC) stock?

ChartMill assigns a valuation rating of 3 / 10 to BLUELINX HOLDINGS INC (BXC). This can be considered as Overvalued.


What is the profitability of BXC stock?

BLUELINX HOLDINGS INC (BXC) has a profitability rating of 2 / 10.


How financially healthy is BLUELINX HOLDINGS INC?

The financial health rating of BLUELINX HOLDINGS INC (BXC) is 6 / 10.